マイクロフルイディクス市場規模、シェア、成長分析：製品別、材料別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

マイクロフルイディクス市場規模は2023年に244億8,000万米ドルとなり、予測期間（2025-2032年）のCAGRは12.8%で、2024年の276億1,000万米ドルから2032年には723億7,000万米ドルに成長する見通しです。

マイクロフルイディクス市場は、慢性疾患や感染症の蔓延、高齢者人口の増加などを背景に急速に拡大しています。マイクロフルイディクスデバイスは、液体や気体のユニークな物理的・化学的特性をマイクロスケールで活用し、より少量のサンプルや試薬を分析することでアプリケーションコストの削減を可能にします。診断、がん検診、細胞操作など、さまざまなプロセスで広く使われています。特に、uFluidix社の生産能力増強と熱可塑性マイクロフルイディクスチップ製造における技術革新に代表されるように、メーカー各社は新市場への参入に向けた取り組みを強化しています。全体として、米国のマイクロフルイディクス市場は、業界の継続的な発展と市場の関心の高まりを反映し、今後数年間は持続的な成長を遂げると予測されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 技術分析
• 価格分析
• バリューチェーン分析
• 市場のエコシステム
• ケーススタディ
• 特許分析
• 顧客と購買基準の分析
• 規制情勢
• マクロ経済指標
• PESTEL分析
• 主な投資の分析
• 主な成功要因
• 競合の程度

マイクロフルイディクス市場：製品別& CAGR（2025-2032）

• 市場概要
• マイクロフルイディクスデバイス
• マイクロフルイディクスコンポーネント
  • マイクロフルイディクスチップ
  • 流量および圧力センサー
  • 流量および圧力コントローラ
  • マイクロポンプ
  • マイクロフルイディクスバルブ
  • マイクロニードル
  • その他のコンポーネント

マイクロフルイディクス市場：素材別& CAGR（2025-2032）

• 市場概要
• ガラス
• シリコン
• ポリマー
• その他

マイクロフルイディクス市場：用途別& CAGR（2025-2032）

• 市場概要
• 体外診断
  • 臨床診断
  • ポイントオブケア検査
  • 獣医診断
• 医薬品およびライフサイエンスの調査と製造
  • ラボ分析
  • プロテオーム解析
  • ゲノム解析
  • 細胞ベースのアッセイ
  • キャピラリー電気泳動
  • マイクロディスペンシング
  • マイクロ反応
• 治療薬
  • ドラッグデリバリー
  • ウェアラブルデバイス

マイクロフルイディクス市場：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院および診断センター
• 学術調査機関
• 製薬・バイオテクノロジー企業

マイクロフルイディクス市場規模：地域別& CAGR（2025-2032）

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific（US）
• Becton, Dickinson, and Company（US）
• Agilent Technologies（US）
• Bio-Rad Laboratories（US）
• F. Hoffmann-La Roche（Switzerland）
• Danaher Corporation（US）
• Illumina Inc.（US）
• Fluidigm Corporation（US）
• Abbott Laboratories（US）
• BioMerieux（France）
• Hologic（US）
• Quidel Corporation（US）
• SMC Corporation（Japan）
• Parker-Hannifin Corporation（US）
• IDEX Corporation（US）
• Fortive Corporation（US）
• Aignep S.p.A（Italy）
• Dolomite Microfluidics（UK）
• Elveflow（France）
• uFluidix（Canada）
• NanoString Technologies（US）
• Nortis Inc.（US）
• Innovative Biochips, LLC（US）
• Fluidic Analytics（UK）

結論と提言

Microfluidics Market size was valued at USD 24.48 billion in 2023 and is poised to grow from USD 27.61 billion in 2024 to USD 72.37 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2025-2032).

The microfluidics market is rapidly expanding, driven by the increasing prevalence of chronic and infectious diseases, as well as the growing elderly population. Microfluidic devices leverage the unique physical and chemical characteristics of liquids and gases at the microscale, allowing for lower application costs by analyzing smaller volumes of samples and reagents. They are widely used in various processes, including diagnostics, cancer screening, and cell manipulation. Notably, manufacturers are intensifying efforts to penetrate new markets, exemplified by uFluidix's recent initiatives to enhance production capacity and innovate in thermoplastic microfluidic chip manufacturing. Overall, the US microfluidics market is projected to experience sustainable growth in the coming years, reflecting the industry's ongoing developments and increasing market interest.

Top-down and bottom-up approaches were used to estimate and validate the size of the Microfluidics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Microfluidics Market Segments Analysis

Global Microfluidics Market is segmented by Product, Material, application, end user and region. Based on Product, the market is segmented into Microfluidics-based Device, Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer, and Others. Based on Application, the market is segmented into In Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics. Based on End User, the market is segmented into Hospital and Diagnostic Centers, Academic and Research Institute, Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Microfluidics Market

The microfluidics market is significantly propelled by innovations in microfluidic technologies, including lab-on-a-chip devices and organ-on-chip systems. These breakthroughs facilitate quicker and more precise diagnostics as well as optimized drug delivery, which are crucial for personalized medicine, point-of-care testing, and pharmaceutical research. As a result, these advancements not only improve healthcare outcomes but also contribute to the overall expansion of the market, responding to the increasing demand for efficient and effective medical solutions. This dynamic growth reflects the ongoing evolution of microfluidics as a vital component in the future of healthcare and life sciences.

Restraints in the Microfluidics Market

One significant constraint hindering the microfluidics market is the lack of awareness and adoption in emerging economies. Many healthcare providers in developing nations are not well-informed about the advantages and uses of microfluidic technologies. This gap in understanding results in slowed integration of these innovative solutions into healthcare systems and contributes to diminished demand for advanced diagnostic and treatment methods. Consequently, the limited penetration of microfluidics in these regions restricts market growth potential and presents challenges for companies seeking to expand their reach and influence in the global healthcare landscape.

Market Trends of the Microfluidics Market

The microfluidics market is witnessing a significant trend towards the increasing demand for point-of-care testing (POC) solutions, driven by the need for rapid and accurate diagnostics. This shift is enhancing patient access to timely healthcare, particularly in remote and rural areas where traditional lab access is limited. The integration of microfluidic technologies in emergency and home healthcare is further fueling this trend, as these devices offer portability, cost-effectiveness, and quick turnaround times for test results. Consequently, the expansion of POC testing is not only transforming patient management strategies but also promoting innovations in microfluidic device design and manufacturing, thereby propelling market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case studies
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Macro-Economic Indicators
• PESTEL Analysis
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Microfluidics Market by Product & CAGR (2025-2032)

• Market Overview
• Microfluidics-based Device
• Microfluidic Components
  • Microfluidic Chip
  • Flow And Pressure Sensors
  • Flow And Pressure Controllers
  • Micropumps
  • Microfluidic Valves
  • Microneedles
  • Other Components

Microfluidics Market by Material & CAGR (2025-2032)

• Market Overview
• Glass
• Silicon
• Polymer
• Others

Microfluidics Market by Application & CAGR (2025-2032)

• Market Overview
• In Vitro Diagnostics
  • Clinical Diagnostics
  • Point of Care Testing
  • Veterinary Diagnostics
• Pharmaceutical & Life Science Research and Manufacturing
  • Lab Analytics
  • Proteomic analysis
  • Genomic analysis
  • Cell-based assays
  • Capillary electrophoresis
  • Microdispensing
  • Microreaction
• Therapeutics
  • Drug Delivery
  • Wearable Devices

Microfluidics Market by End-user & CAGR (2025-2032)

• Market Overview
• Hospital and Diagnostic Centers
• Academic and Research Institute
• Pharmaceutical & Biotechnology Companies

Microfluidics Market Size & CAGR (2025-2032)

• Market Overview
• North America (Product, Material, Application, End User)
  • US
  • Canada
• Europe (Product, Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson, and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker-Hannifin Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEX Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortive Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aignep S.p.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dolomite Microfluidics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elveflow (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• uFluidix (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nortis Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovative Biochips, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidic Analytics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations